TT&A, Farooq and Associates advise IFC on sanctioning $30 million to Popular Pharma
The International Finance Corporation is set to extend a loan aggregating up to $30.7 million to Popular Pharmaceuticals PLC, a company incorporated in Bangladesh. TT&A advised IFC on this financing transaction. The transaction team consisted of Gautam Saha (Managing Partner), Nikhil Bahl (Partner), Ankita Mandal (Managing Associate) and Manasvini Vyas (Associate). Gautam Saha, Nikhil Bahl TT&A had recently advised IFC on sanctioning loans for Bangladesh-based PRAN-RFL Group companies.
Sources
- Bar & Bench - Dealstreet
- RBI notifications · official
- BSE corporate announcements · official
- NSE corporate announcements · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- TT&A, A&O Shearman advise broker on sale of ₹250 crore Anthem Biosciences shares by Portsmouth Tech26 Oct 2026 · ₹250 cr
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026